Linio Biotech Ltd
Linio Biotech is a pioneering company in regenerative aesthetics, focusing on skin regeneration and soft tissue restoration. With a foundation in scientific research and innovation, they develop ready-to-use tissue products like Tience® that harness the regenerative power of adipose tissue. Their mission is to revolutionize skin treatments by providing safe, effective, and accessible solutions that promote natural healing and long-lasting results, aiming to become a global leader in regenerative aesthetics.
Industries
Nr. of Employees
small (1-50)
Linio Biotech Ltd
Helsinki, Southern Finland, Finland, Europe
Products
Ready-to-use human-origin adipose-derived cell-free regenerative product
A sterile, cell-free product derived from human adipose tissue designed to deliver regenerative bioactive components to improve skin function, structure and elasticity for medical aesthetic applications.
Ready-to-use human-origin adipose-derived cell-free regenerative product
A sterile, cell-free product derived from human adipose tissue designed to deliver regenerative bioactive components to improve skin function, structure and elasticity for medical aesthetic applications.
Services
R&D collaboration for tissue-derived regenerative products
Co-development and research partnerships focused on applying adipose-derived regenerative technology to new medical devices and clinical applications.
Manufacturing and tissue establishment services
Production and manufacturing capability for tissue-origin regenerative products at a dedicated tissue establishment facility in Finland, with CDMO collaboration options for scale-up.
Regulatory and commercialization support
Strategic support for regulatory classification, pathway planning toward EU and FDA approvals, and commercial partnership development for tissue products.
R&D collaboration for tissue-derived regenerative products
Co-development and research partnerships focused on applying adipose-derived regenerative technology to new medical devices and clinical applications.
Manufacturing and tissue establishment services
Production and manufacturing capability for tissue-origin regenerative products at a dedicated tissue establishment facility in Finland, with CDMO collaboration options for scale-up.
Regulatory and commercialization support
Strategic support for regulatory classification, pathway planning toward EU and FDA approvals, and commercial partnership development for tissue products.
Expertise Areas
- Regenerative aesthetics
- Adipose tissue engineering
- Cell-free tissue product development
- Sterile tissue product manufacturing
Key Technologies
- Adipose-derived regenerative extracts
- Cell-free tissue formulation
- Tissue engineering methods
- Sterile tissue establishment and manufacturing